SCHOTT Presents New Vials and Syringes at CPhI 2014
SCHOTT will present the adaptiQ ready-to-use vials, syriQ prefilled syringes, and the TopPac Polymer syringes at CPhI Worldwide 2014 in Paris.
SCHOTT glass manufacturers will be attending CPhI Worldwide 2014 in Paris, France. SCHOTT will host a series of six lectures at booth 2G69 in hall 2, featuring experts speaking about preventive measures for glass breakage, packaging options, and processing limits. Alongside the six lectures, SCHOTT will display three of its products at the CPhI booth.
On display will be the syriQ prefilled syringe for highly sensitive biotech drug substances complete with tamper-evident closure, avoidance of premature needle to drug exposure, and avoidance of stick to needle shield exposure. Also on display will be the adaptiQ nest and tub-configuration ready-to-use vials that allow for direct filling, freeze-drying, weighing, and closing inside the nest and the TopPac polymer syringes, which are designed to be break-resistant, lightweight, and transparent and feature the ability to administer highly-viscous drugs and large volumes via infusion pumps.
Source: SCHOTT
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
